Inpatient falls in older adults:a cohort study of antihypertensive prescribing pre- and post-fall by Omer, H. M. R. B. et al.
 
 
Inpatient falls in older adults
Omer, H. M. R. B.; Hodson, James; Pontefract, Sarah; Martin, Una
DOI:
10.1186/s12877-018-0749-8
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Omer, HMRB, Hodson, J, Pontefract, SK & Martin, U 2018, 'Inpatient falls in older adults: a cohort study of
antihypertensive prescribing pre- and post-fall', BMC Geriatrics, vol. 18, 58. https://doi.org/10.1186/s12877-018-
0749-8
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
RESEARCH ARTICLE Open Access
Inpatient falls in older adults: a cohort
study of antihypertensive prescribing pre-
and post-fall
H. M. R. B. Omer1, J. Hodson2, S. K. Pontefract2,3 and U. Martin2,3*
Abstract
Background: Falls are common during hospital admissions and may occur more frequently in patients who are
taking antihypertensive medications, particularly in the context of normal to low blood pressure. The review and
adjustment of these medications is an essential aspect of the post-fall assessment and should take place as soon as
possible after the fall.
Our aim was to investigate whether appropriate post-fall adjustments of antihypertensive medications are routinely
made in a large National Health Service (NHS) Trust.
Methods: Inpatient records over an eight-month period were captured from an electronic prescribing system to
identify older adults (≥80 years old) with normal/low blood pressures (< 140 mmHg systolic) who had a documented
inpatient fall as these patients were considered to be at high risk of further falls. Prescribed antihypertensive
medication on admission was then compared with the post-fall (within 24 h after the fall) and discharge prescriptions.
Results: A total of 146 patients were included in the analysis. Of those, 120 patients (82%) were taking the same
number of antihypertensive medications in the 24 h after the fall as they were before; only 19 patients (13%) had a
reduction in the number of medications and seven patients (5%) had an increase in medications during that period.
Only 9% of the antihypertensive classes assessed were either stopped or reduced in dose immediately post-fall. In
addition, 11 new antihypertensives were prescribed at this time.
At discharge, half of the patients (n= 73) remained on the same number of antihypertensive medication as on admission,
51 patients (35%) were on fewer antihypertensives and 22 (15%) were on more. Additionally, no changes were made to
individual antihypertensives in 49% of prescriptions; 34% were stopped or reduced in dose but 38 new agents were
started by the time of discharge. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers (ACEi/
ARB) were the class of medications most commonly stopped or reduced (51%).
Conclusions: Antihypertensive prescriptions are frequently unchanged after an inpatient fall. Routine medication review
needs to be part of post-fall assessments in hospital to reduce the risk of further falls.
Keywords: Antihypertensive, Medication review, Postural hypotension
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Background
Falls are a frequent occurrence in the hospital setting,
and remain the most common patient safety incident re-
ported by organisations [1]. They have the potential to
cause significant injuries, particularly among older
adults, thereby extending length of stay and prolonging
recovery times [2]. Falls therefore incur a substantial
cost to National Health Service (NHS) hospitals [3].
With an average fall rate of 6.63 per 1000 occupied bed
days across England and Wales in 2015 [1], there is an
urgent need to implement preventative strategies and
after care for patients post-fall.
There are multiple risk factors associated with falls,
which can be broadly divided into extrinsic (due to
environmental factors) and intrinsic (due to the
physiology of ageing and individual comorbidities) [4].
Extrinsic factors are the commonest cause of falls in the
older adult population and include physical obstacles, poor
lighting, slippery upholstery and the absence of physical
aids such as hand rails [5, 6]. Intrinsic factors include
changes to vision, hearing, muscle power, balance and gait
[4]. Physiological changes, combined with other extrinsic
factors, contribute to a large proportion of falls in older
adults [4, 5]. There are certain conditions which also in-
crease the risk of falls. One such condition is orthostatic
hypotension, defined as a postural drop in blood pressure
of at least 20 mmHg systolic and/or 10mmgHg diastolic
within 3 min of being upright [7]. During the ageing
process, there is often a reduction in blood vessel compli-
ance, which leads to an increase in systemic vascular
resistance and a resultant increase in blood pressure [8].
In certain older adults however, the development of condi-
tions affecting the autonomic nervous system can negate
the changes in blood vessel compliance, resulting in
orthostatic hypotension [9] and an increased risk of falls.
Hypertension is a common condition and use of antihy-
pertensive and vasoactive medications have been associ-
ated with falls in older adults, partly because their use is
associated with orthostatic changes in addition to adverse
effects such as dizziness and gait disturbance [10, 11]. For
this reason, more modest target blood pressures of 150/
90 mmHg have been set in older adults over 80 years as
this group receive marked cardiovascular benefits even at
this level of control [12, 13]. This highlights the import-
ance of a medication review by the responsible clinician in
both the primary and secondary prevention of falls in
older adults [14], particularly if the blood pressure is much
lower than the advised target. In addition to having any
physical injuries managed, patients need to be assessed for
any potential contributing factors to the fall. Interventions
may include a reduction in antihypertensive medication to
try to prevent a second fall.
This study investigates how antihypertensive medications
are managed post-inpatient fall in a high-risk cohort of
older adults (≥80 years old) with normal/low blood
pressure (< 140 mmHg systolic).
Methods
Setting
This work was conducted in a large acute NHS Hospital
in the United Kingdom (UK). The hospital has an elec-
tronic prescribing and medications administration
(EPMA) system known as PICS (Prescribing, Information
and Communication System). The system is in use across
both inpatient medical and surgical specialties. One bene-
fit of the system is that it also captures data on reported
falls across all (~ 1200) inpatient beds [15]. Information
from the system is then exported to an audit database on
a weekly basis, thus facilitating subsequent analysis.
Data collection
Data on all reported falls occurring between 1 January
and 31 August 2014 were captured from the PICS audit
database. For each patient with a documented fall, the
first fall per patient was included in the analyses, to en-
sure that all cases were independent. Falls that occurred
within 24 h of admission were excluded, as these cases
may have given insufficient time for a patient’s pre-fall
medication regimen to be established and reflected on
the system. Older adults (≥80 years old) with relatively
normal/low blood pressures (< 140 mmHg systolic) were
then selected as these patients were considered to be at
high risk of further falls, and would therefore require an
urgent and thorough medication review as part of a
post-fall assessment. Only patients that were prescribed
antihypertensive medications as defined by the National
Institute for Health and Care Excellence (NICE) guid-
ance [13] and/or other medications with antihyperten-
sive properties (angiotensin converting enzyme
inhibitors or angiotensin II receptor blockers (ACEi/
ARB), beta blockers, calcium channel blockers (CCB),
diuretics, nitrates and others), were included in the study
as shown in Table 1. Information was collected on the
total number of antihypertensives prescribed before the
fall, in the 24 h after the fall and at discharge. Information
was then collected about the changes to the prescription
of these individual classes of drugs in the 24 h after the fall
and again at discharge including whether they were
stopped or started or whether the doses were increased or
reduced at these time points.
The study flowchart is reported in Fig. 1.
For the patients included in the study, a range of
demographic and physiological factors were captured for
the pre-fall stage, defined as the period of time between
24 h after admission and the fall being documented. For
multiple data entries, data closest to the point of the fall
occurring was captured. All active prescriptions for the
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patients were recorded at this time, as well as post-fall
(within 24 h after the fall) and at discharge (those
documented on the discharge prescription).
Statistical methods
Initially, the data were analysed on a patient level. The
total number of antihypertensives prescribed for a patient
at the post-fall and discharge time points were compared
to pre-fall using Wilcoxon’s signed-rank tests.
The data were then analysed on a medication level to
consider dose changes and differences in prescribing be-
haviour across classes of medications. Where patients
were prescribed a medication, the total daily dose was
calculated at the three time points, with a dose of zero
used if the medication was not being prescribed at that
time. Wilcoxon’s signed-rank tests were then used to as-
sess the change over time in these doses. The changes in
doses were then compared between the medications. To
account for the differing magnitudes of doses across the
medications, an ordinal variable was produced, which
categorised the change in dose as: stopped, reduced, no
change, increased or started. This was then compared
between the medications using a Kruskal-Wallis test.
All analyses were performed using IBM SPSS 22 (IBM
Corp. Armonk, NY), with p < 0.05 deemed to be indica-
tive of statistical significance throughout. Continuous
variables are reported as medians and interquartile
ranges (IQRs).
Results
Data were available for 146 patients (Table 2). The me-
dian pre-fall systolic blood pressure was low across the
entire cohort, 122 mmHg (IQR: 109-127 mmHg). Most
patients in the study were under the care of the medical
directorate and the median time to fall in the cohort was
7.2 days from admission.
In the pre-fall period, most patients were prescribed
one (n = 66, 45%) or two (n = 35, 24%) antihypertensives
(Table 3). In the 24 h after the fall 120 patients (n = 120,
82%) were taking the same number of antihypertensive
medications as they were before; only 19 patients (13%)
Table 1 Medications with antihypertensive properties captured
on PICS for each inpatient fall
ACEi/ARB Beta blockers CCB
Enalapril Atenolol Amlodipine
Irbesartan Bisoprolol Diltaizem
Lisinopril Carvedilol Lercanidipine
Losartan Metoprolol Nifedipine
Perindopril Nebivolol Nimodipine
Quinapril Propranolol Tildiem
Ramipril Sotalol Verapamil
Telmisartan Timolol
Valsartan
Diuretics Nitrates Others
Acetazolamide Glyceryl trinitrate Alfuzosin
Bendroflumethiazide Isosorbide dinitrate Doxazosin
Bumetanide Isosorbide mononitrate Eplerenone
Co-amilofruse Moxonidine
Furosemide Prazosin
Indapamide Spironolactone
Fig. 1 Inclusion and exclusion criteria for inpatient falls
Table 2 Overall Patient Demographics
Age at Admission [Years] 86 [83–90]
Gender
Male 79 [54%]
Female 67 [46%]
Ethnicity
Caucasian 135 [92%]
Other 11 [8%]
Directoratea
Medical 111 [77%]
Surgical 34 [23%]
Days from Admission to Fall 7.2 [2.7–16.5]
Pre-Fall Systolic BP 122 [109–127]
Pre-Fall Diastolic BP 64 [57–70]
Pre-Fall Heart Rate 79 [65–87]
Data reported as median [IQR] or N [%] as applicable
aBased on N = 145, after excluding one Critical Care patient
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had a reduction in the number of medications, whilst
the number of medications increased in seven patients
(5%) during that period.
Analyses were then performed to consider whether
changes were made in the post-fall period to the doses
of the antihypertensive agents prescribed. Compared to
the pre-fall period, no significant change in doses was
detected post-fall (p = 0.129, Table 4), with 86% of pre-
scriptions remaining the same. Only 9% (n = 26) of the
antihypertensive classes assessed were either stopped or
reduced immediately post-fall. In addition, 11 new anti-
hypertensives were prescribed at this time (Table 4).
At discharge, half of the patients (n = 73, 50%)
remained on the same number of antihypertensive medi-
cation as on admission, just over a third of patients (n =
51, 34%) were on a fewer number and 15% (n = 22) were
on more (Table 3). However, between the pre-fall and
discharge period, a significant reduction in doses of anti-
hypertensives was detected (p < 0.001, Table 5), with 7%
of prescriptions changed to lower doses, and a further
27% stopped completely. Nonetheless, 4% of prescrip-
tions were changed to a higher dose and 12% of new
prescriptions for antihypertensives were started by the
time of discharge. Across the individual antihypertensive
classes a significant difference was detected across the
groups (p = 0.022), with the ACEi/ARB group found to
have the most frequent dose reductions, with 9% of pre-
scriptions being reduced in dose, and 42% stopped
completely by discharge.
Discussion
This retrospective study conducted in a large acute NHS
hospital explored how antihypertensive medications are
managed post-inpatient fall. Older adults (≥80 years old)
with relatively low blood pressures (< 140 mmHg systolic)
were included in the study, as they were potentially at
high-risk of further falls. It was assumed that any changes
to antihypertensive medications reflected “a medication re-
view”. In some cases, a review may have been conducted
and a decision made not to change the medication. As
such, the rates of prescription review could not be implied.
The study demonstrated that few patients had their anti-
hypertensives altered immediately post-fall, with most pa-
tients remaining on the same number of medications and
at the same doses. This was of some concern, particularly
since this was a cohort of patients with relatively low pre--
fall blood pressures. Whilst the cause for this was
unknown, it should have warranted a close review of
patients’ antihypertensive medications with a view to redu-
cing or stopping doses, particularly once a fall had oc-
curred. This alteration occurred in only a small number of
cases. This may reflect a lack of awareness of guidelines
on the management and prevention of falls, which empha-
sises the importance of reviewing at risk medications as
part of a multifactorial risk assessment for all patients,
particularly those aged over 65 years [3]. The UK Single
Competency Framework for all prescribers also highlights
the need for management plans to be adapted as a result
of patient monitoring, comorbidities and preferences [16].
Reassuringly, where prescriptions were changed, the
Table 3 Number of antihypertensives prescribed
Pre-Fall Post-Fall Discharge
No. Antihypertensives
0 9 [6%] 13 [9%] 33 [23%]
1 66 [45%] 66 [45%] 55 [38%]
2 35 [24%] 33 [23%] 28 [19%]
3 20 [14%] 18 [12%] 17 [12%]
4 10 [7%] 11 [8%] 7 [5%]
5 4 [3%] 3 [2%] 5 [3%]
6 2 [1%] 2 [1%] 0 [0%]
7 0 [0%] 0 [0%] 1 [1%]
Change from Pre-fall P = 0.031* P < 0.001*
Fewer – 19 [13%] 51 [35%]
Same Number – 120 [82%] 73 [50%]
More – 7 [5%] 22 [15%]
*Wilcoxon’s signed-rank test comparing the number of hypertensives with the
pre-fall period
Table 4 Changes to prescriptions from pre-fall to 24 h post-fall
Change Pre-Fall to Post-Fall
Na Stopped Reduced No Change Increased Started
ACEi/ARB 52 6 [12%] 0 [0%] 44 [85%] 0 [0%] 2 [4%]
Beta blockers 53 4 [8%] 0 [0%] 46 [87%] 0 [0%] 3 [6%]
CCBs 26 2 [8%] 0 [0%] 24 [92%] 0 [0%] 0 [0%]
Diuretics 85 9 [11%] 3 [4%] 67 [79%] 1 [1%] 5 [6%]
Nitrates 41 0 [0%] 1 [2%] 39 [95%] 0 [0%] 1 [2%]
Other 22 1 [5%] 0 [0%] 21 [95%] 0 [0%] 0 [0%]
Total 279 22 [8%] 4 [1%] 241 [86%] 1 [0%] 11 [4%]
Comparison of pre-fall vs. post-fall doses across all drug groups (Wilcoxon’s signed-rank test): p = 0.129
aThe number of cases where the medication was prescribed in either the pre-fall or post-fall period
Omer et al. BMC Geriatrics  (2018) 18:58 Page 4 of 6
tendency was to reduce the numbers and doses of antihy-
pertensives prescribed. However, in a small number of
cases, new antihypertensive medications were started in
the 24 h following the fall.
At the point of discharge, changes in antihypertensive
prescribing were observed more frequently, although
half of the cohort was still on the same number of medi-
cations at this point and almost half (49%) of the pre-
scriptions had no change in dose. Reductions in the
numbers and/or doses of antihypertensives, relative to
pre-fall, were only observed in approximately one third
of the cohort at discharge.
All antihypertensives assessed in the study had the
propensity to cause vasodilator effects and thus increase
the risk of falls. According to the screening tool of older
person’s prescriptions (STOPP) criteria, such antihyper-
tensive medications should only be stopped in patients
with persistent postural hypotension [17]. As such, it
may have been that only some patients had documented
postural changes and, thus, few had their antihyperten-
sive medication(s) either stopped or reduced. Whilst the
study documented pre-fall blood pressures, it was not
possible to determine if postural changes were the cause
as standing blood pressures were not documented.
In regard to doses of antihypertensives, whilst no sig-
nificant difference was seen between the pre-fall and
post-fall period, there was a significant change in medi-
cation doses between the pre-fall and discharge period,
with around a third of antihypertensives either stopped
or reduced. The more frequent change in doses at dis-
charge could reflect the input of pharmacists who tend
to review medications prior to patients being sent home.
Interestingly however, some patients were prescribed a
greater number of antihypertensives at both the post-fall
and discharge period which might be of concern if it
caused a lower blood pressure and thereby increased the
risk of further falls.
The most significant changes to antihypertensive doses
in the discharge period occurred in the ACEi/ARB
group. This may reflect adherence to national guidelines,
where this group of medications are not considered
first-line in older patients with hypertension. In addition,
it may be that medical professionals feel that it is more
critical to alter doses of these medications compared to
other medications analysed in the study. Indeed, stop-
ping ACEi or ARBs is common place in patients with
suspected renal dysfunction, which occurs more
commonly in older patients.
Limitations
This study was based on falls data recorded within PICS,
which is reliant on accurate documentation. Medication
data recorded in PICS allowed us to determine changes
that occurred across three time points accurately. However,
the reasons for any changes, or lack of changes to regimens
were not documented. As such, any changes to post-fall or
discharge medications were assumed to be related to the
inpatient fall event. In addition, for patients without docu-
mented prescription changes, it is unknown if the prescrip-
tions were either not reviewed or whether an active
decision was made not to change prescriptions following
review. Finally, the reasons for falls occurring could not be
determined in the study due to incomplete data.
Conclusions
Whilst there was evidence that some patients had their
antihypertensive medications reviewed and altered at
discharge, most patients had no documented changes to
their antihypertensive medications immediately post-fall,
which suggests that a review did not take place. This
suggests that patients’ medications may not be ad-
equately reviewed as part of the multi-factorial assess-
ment of each fall, as recommended by national guidance,
and broadly by prescribing competencies. This empha-
sises the need to raise awareness of the guidelines and
provide education about medications associated with
falls, how best to adjust regimens and monitor effects in
patients, to improve standards of care.
Table 5 Changes to prescriptions from pre-fall to discharge
Change Pre-Fall to Discharge
Na Stopped Reduced No Change Increased Started
ACEi/ARB 53 22 [42%] 5 [9%] 22 [42%] 1 [2%] 3 [6%]
Beta blockers 59 9 [15%] 3 [5%] 35 [59%] 3 [5%] 9 [15%]
CCBs 31 9 [29%] 0 [0%] 16 [52%] 1 [3%] 5 [16%]
Diuretics 92 28 [30%] 7 [8%] 38 [41%] 7 [8%] 12 [13%]
Nitrates 46 7 [15%] 5 [11%] 28 [61%] 0 [0%] 6 [13%]
Other 25 9 [36%] 1 [4%] 11 [44%] 1 [4%] 3 [12%]
Total 306 84 [27%] 21 [7%] 150 [49%] 13 [4%] 38 [12%]
aThe number of cases where the medication was prescribed either pre-fall or at discharge
Comparison of pre-fall vs. discharge doses across all drug groups (Wilcoxon’s signed-rank test): p < 0.001 Comparison of the change in doses from pre-fall to
discharge between drug groups (Kruskal-Wallis test): p = 0.022
Omer et al. BMC Geriatrics  (2018) 18:58 Page 5 of 6
Abbreviations
ACEi/ARB: Angiotensin converting enzyme inhibitors and angiotensin II
receptor blockers; CCB: Calcium channel blockers; EPMA: Electronic
Prescribing and Medications Administration; IQR: Interquartile range;
NHS: National Health Service; NICE: National Institute for Health and Care
Excellence; PICS: Prescribing, Information and Communication System;
STOPP: Screening Tool of Older Person’s Prescriptions; UK: United Kingdom
Acknowledgements
The authors would like to thank the Informatics department at the University
Hospital Birmingham NHS Foundation Trust for capturing the data from the
PICS audit database to conduct this study.
Funding
This work was unfunded. No financial sponsors played any role in the
design, collection, analysis and interpretation of data, or writing of the study.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
SP, UM and HO had the initial idea for the study. SP and HO extracted the
data from the Trust electronic prescribing system and JH analysed the falls
data. All authors had full access to all the data (including statistical reports
and tables) in the study and can take responsibility for the integrity of the
data and the accuracy of the data analysis. HO was a major contributor in
writing the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The project did not require NHS Research Ethics Committee approval
because it was classified as a clinical audit according to the NHS Health
Research Authority defining research tool [18]. The study was approved by
the Research and Development department at the University Hospitals
Birmingham NHS Foundation Trust.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
2University Hospitals Birmingham NHS Trust, Birmingham, UK. 3College of
Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT,
UK.
Received: 21 September 2017 Accepted: 15 February 2018
References
1. Vasilakis N, Schoo R, O'Riordan S, Rai S, Stanley R, Barker L. National Audit of
Inpatient Falls: audit report 2015. Royal College of Physicians. 2015. https://
www.rcplondon.ac.uk/projects/outputs/naif-audit-report-2015. Accessed 1
Jan 2016.
2. Healey F, Scobie S, Oliver D, Pryce A, Thomson R, Glampson B. Falls in
English and welsh hospitals: a national observational study based on
retrospective analysis of 12 months of patient safety incident reports. Qual
Saf Health Care. 2008;17:424–30.
3. Falls in older people: assessing risk and prevention. NICE clinical guideline
161. 2013. https://www.nice.org.uk/guidance/cg161. Accessed 1 Jan 2016.
4. Pasquetti P, Apicella L, Mangone G. Pathogenesis and treatment of falls in
elderly. Clin Cases Miner Bone Metab. 2014;11:222–5.
5. Rubenstein LZ. Falls in older people: epidemiology, risk factors and
strategies for prevention. Age Ageing. 2006;35:37–41.
6. Shuto H, Imakyure O, Matsumoto J, Egawa T, Jiang Y, Hirakawa M, et al.
Medication use as a risk factor for inpatient falls in an acute care hospital: a
case-crossover study. Br J Clin Pharmacol. 2010;69:535–42.
7. Kaufmann H. Consensus statement on the definition of orthostatic
hypotension, pure autonomic failure and multiple system atrophy. Clin
Auton Res. 1996;6:125–6.
8. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J. 2006;
82(968):357–62.
9. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS
guidelines on the diagnosis and management of orthostatic hypotension.
Eur J Neurol. 2006;13:930–6.
10. Tinetti ME, Han L, Lee DS, GJ MA, Peduzzi P, Gross CP, et al.
Antihypertensive medications and serious fall injuries in a nationally
representative sample of older adults. JAMA Intern Med. 2014;174(4):588.
11. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al.
Adverse medicine events in ambulatory care. N Engl J Med. 2003;348:
1556–64.
12. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al.
Treatment of hypertension in patients 80 years of age or older. N Engl J
Med. 2008;358(18):1887–98.
13. Hypertension in adults: diagnosis and management. NICE clinical guideline
127. 2016. https://www.nice.org.uk/guidance/cg127. Accessed 1 Jan 2016.
14. Berry SD, Kiel DP. Treating hypertension in the elderly. JAMA Intern Med
American Medical Association. 2014;174:596.
15. Nightingale PG, Adu D, Richards NT, Peters M. Implementation of rules
based computerised bedside prescribing and administration: intervention
study. BMJ. 2000;320:750–3.
16. Picton C. A competency framework for all prescribers. Royal Pharmaceutical
Soceity. 2016. https://www.rpharms.com/resources/frameworks/prescribers-
competency-framework. Accessed 24 June 2016.
17. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P.
STOPP/START criteria for potentially inappropriate prescribing in older
people: version 2. Age Ageing. 2015;44:213–8.
18. Is my study research? NHS Health Research Authority. http://www.hra-decisiontools.
org.uk/research/docs/DefiningResearchTable_Oct2017-1.pdf. Accessed 7 Feb 2018.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Omer et al. BMC Geriatrics  (2018) 18:58 Page 6 of 6
